Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 55294-15-0, Edrul, Muzolimina, Bay g 2821, Bay-g-2821, Bay-g 2821; edrul
Molecular Formula
C11H11Cl2N3O
Molecular Weight
272.13  g/mol
InChI Key
RLWRMIYXDPXIEX-UHFFFAOYSA-N
FDA UNII
07Z36289ZX

A pyrazole diuretic with long duration and high capacity of action. It was proposed for kidney failure and hypertension but was withdrawn worldwide because of severe neurological effects.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-4H-pyrazol-3-one
2.1.2 InChI
InChI=1S/C11H11Cl2N3O/c1-6(16-11(17)5-10(14)15-16)7-2-3-8(12)9(13)4-7/h2-4,6H,5H2,1H3,(H2,14,15)
2.1.3 InChI Key
RLWRMIYXDPXIEX-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C1=CC(=C(C=C1)Cl)Cl)N2C(=O)CC(=N2)N
2.2 Other Identifiers
2.2.1 UNII
07Z36289ZX
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Bay G 2821

2. G 2821, Bay

2.3.2 Depositor-Supplied Synonyms

1. 55294-15-0

2. Edrul

3. Muzolimina

4. Bay G 2821

5. Bay-g-2821

6. Bay-g 2821; Edrul

7. 3-amino-1-(1-(3,4-dichlorophenyl)ethyl)-1h-pyrazol-5(4h)-one

8. Bay-g 2821

9. 07z36289zx

10. Muzolimina [spanish]

11. 3h-pyrazol-3-one, 5-amino-2-(1-(3,4-dichlorophenyl)ethyl)-2,4-dihydro-

12. 3h-pyrazol-3-one, 5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-2,4-dihydro-

13. Muzoliminum

14. Muzoliminum [inn-latin]

15. Muzolimina [inn-spanish]

16. Einecs 259-573-2

17. Brn 0660881

18. Muzolimine [usan:inn:ban]

19. Unii-07z36289zx

20. 5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-4h-pyrazol-3-one

21. Muzolimine [mi]

22. 3-amino-1-(3,4-dichloro-alpha-methylbenzyl)-2-pyrazolin-5-one

23. Muzolimine [inn]

24. Muzolimine (usan/inn)

25. Muzolimine [usan]

26. 3-amino-1-(3,4-dichloro-alpha-methylbenzyl)-4,5-dihydro-5-pyrazolon

27. 3h-pyrazol-3-one, 2,4-dihydro-5-amino-2-(1-(3,4-dichlorophenyl)ethyl)-

28. 5-amino-2-(1-(3,4-dichlorophenyl)-ethyl)-2,4-dihydro-3h-pyrazol-3-one

29. Muzolimine [mart.]

30. Muzolimine [who-dd]

31. Schembl123392

32. Chembl1697760

33. Dtxsid50866476

34. Chebi:135124

35. 5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-2,4-dihydro-3h-pyrazol-3-one

36. Db13801

37. Da-04927

38. Hy-106616

39. Cs-0026158

40. Ft-0759718

41. D05093

42. Q3868794

43. 3-amino-1-(3,4-dichloro-a-methylbenzyl)-2-pyrazolin-5-one

44. 3-amino-1-(3,4-dichloro-.alpha.-methylbenzyl)-2-pyrazolin-5-one

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 272.13 g/mol
Molecular Formula C11H11Cl2N3O
XLogP32
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass271.0279174 g/mol
Monoisotopic Mass271.0279174 g/mol
Topological Polar Surface Area58.7 Ų
Heavy Atom Count17
Formal Charge0
Complexity348
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


Diuretics

Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)


4.2 ATC Code

C - Cardiovascular system

C03 - Diuretics

C03C - High-ceiling diuretics

C03CD - Pyrazolone derivatives

C03CD01 - Muzolimine